Table 3.
Effects of different doses of MECP on blood glucose levels in the treatment period
| Animal Group | Blood glucose concentration in mg/dl* | |||
|---|---|---|---|---|
| 1st day | 7th day | 14th day | 21st day | |
| G-I Vehicle control | 112.62 ± 3.12 | 105.44 ± 4.04 | 108.12 ± 3.03 | 116.49 ± 3.86 |
| G-II STZ induced | 298.21 ± 12.81 | 306.88 ± 13.05 | 316.48 ± 13.11 | 323.64 ± 14.05# |
| G-III Test 1 (50 mg/kg) | 312.61 ± 26.53 | 311.12 ± 13.53 | 308.50 ± 24.66 | 314.21 ± 18.65 |
| G-IV Test 2 (100 mg/kg | 289.09 ± 11.63 | 280. 05 ± 15.15 | 282.63 ± 8.91 | 278.15 ± 9.66 |
| G-V Test 3 (200 mg/kg | 305.01 ± 13.81 | 278.89 ± 18.60 | 206.64 ± 12.22 | 123.89 ± 9.60# |
| G-VI Standard drug | 294.41 ± 6.53 | 264.15 ± 7.12 | 142.80 ± 4.05 | 109.81 ± 6.61# |
*Values are mean ± SEM (n = 6)
#Values are statistically significant at (P < 0.05)